FREMONT, Calif. & LAS VEGAS--(BUSINESS WIRE)--Myoscience, Inc., a medical device company dedicated to relieving pain through targeted therapies, today announced clinical trial results demonstrating ...

Iovera treatment uses a little wand to freeze out knee pain. Dr. Joshua Urban, at OrthoNebraska, is the first doctor in the state to use the treatment. Urban said it is approved to treat knee pain.

BETTENDORF, Iowa — A UnityPoint Health - Trinity doctor is using an innovative procedure to improve recovery after a knee replacement surgery. Dr. Maruti Kari in the hospital's pain management clinic ...

Surgery may be in your future, but a painful recovery doesn’t have to be. Physicians can help pave the way for a smooth recovery before a patient even gets to the hospital. The iovera° treatment is a ...

local doctor helped develop and create a treatment that reduces the need for opioid pain meds. He's treating people before they have knee replacement surgery by freezing the nerves in the knee. We go ...

(WEAR) — Knee pain can be hard to manage, and treatments like steroids or pharmaceuticals can have strong side effects. A non-surgical treatment called Iovera gives many patients an alternative.

Lane Regional Medical Center is one of the first hospitals in the region to adopt Iovera technology, a clinically proven, nonopioid, pain management solution for relief of chronic and acute knee pain, ...

In 2021, it was estimated that about 23% of adults living in Las Vegas, NV had arthritis. Osteoarthritis (OA), the most common form of arthritis, affects millions of people worldwide. OA symptoms can ...

Nancy Shultz, 69, is looking forward to getting back out on the golf course. “I have hope now that I’ll play sooner than I thought I might,” she says. That’s because Nancy is recovering quicker than ...

TAMPA, Fla., March 15, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today ...

Shares of Pacira Pharmaceuticals Inc. fell 1.9% in premarket trade Tuesday after the company announced it was planning to acquire MyoScience Inc., a privately-held company that markets an FDA-approved ...